Please provide your email address to receive an email when new articles are posted on . When performing cataract surgery in patients treated with intravitreal injections, be aware of the increased ...

An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...

Please provide your email address to receive an email when new articles are posted on . The most common ophthalmic procedure is an intravitreal injection, with more than 10 million per year performed ...

If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...

Patients with retinal vein occlusion-related macular edema had a higher likelihood of blindness and low vision if they had low best-corrected visual acuity after 1 month of intravitreal treatment.

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...

Application of topical anesthetic drops may be more effective at reducing pain caused by intravitreal injection, according to an OSN SuperSite report. Gregory R. Blaha, MD, PhD, one of the study’s ...

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

New study from University of California, Irvine and University of California, Santa Barbara researchers demonstrates improved retinal function and vascular integrity, supporting further investigation ...

NORTHBROOK, Ill., March 26, 2024 /PRNewswire/ -- Iveric Bio, An Astellas Company (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Centers for Medicare and Medicaid ...

LONG BEACH, Calif. -- Two different ocular implants eluting an endothelin antagonist showed early promise for slowing diabetic eye disease, according to two small studies reported here. In a ...